Market Updates
Albireo Pharma Agreed Ipsen's Merger Proposal
Scott Peters
09 Jan, 2023
New York City
Albireo Pharma Inc soared 92% to $43.82 after the US-based rare liver disease focused company agreed to merge with the French biopharma company Ipsen.
Ipsen SA increased 0.5% to
Annual Returns
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|